United States Biotechnology & Medical Research

Akero Therapeutics Inc (AKRO)

Track

Track

Akero Therapeutics experienced multiple insider transactions throughout September and October 2025. Key executives, including the CEO, CFO, and COO, executed various planned and proposed sales of company stock. These divestments represent the most recent activity, with the final recorded trades occurring on October 10, 2025.
Ticker: AKRO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Akero Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
113.80
Quantity 83,338 +30.9%
Value US$3,062,554
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
449.07
Quantity 77,941 -29.8%
Value US$2,761,343
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
321.29
Quantity 21,281 +47.3%
Value US$2,152,867
4.1
Timothy Rolph Officer Officer
Transaction date
Proposed sale
Price
46.04
Quantity 56,369
Value US$2,595,229
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Planned sale
Price
47.98
Quantity 4,201 -2.1%
Value US$201,581
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Planned sale
Price
47.64
Quantity 8,299 -4.0%
Value US$395,398
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Sale
Price
43.02
Quantity 586 -0.3%
Value US$25,210
3.8
White William Richard Chief Financial Officer Officer
Transaction date
Sale
Price
43.02
Quantity 659 -1.1%
Value US$28,350
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Sale
Price
43.02
Quantity 1,796 -0.4%
Value US$77,264
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Sale
Price
43.02
Quantity 659 -0.7%
Value US$28,350
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Sale
Price
43.02
Quantity 553 -0.3%
Value US$23,790
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
44.62
Quantity 158 -0.0%
Value US$7,050
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
44.00
Quantity 7,317 -1.5%
Value US$321,911
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
42.99
Quantity 22,525 -4.5%
Value US$968,440
3.3
Andrew Cheng President, CEO and Director Non-Executive Director
Transaction date
Proposed sale
Price
44.62
Quantity 90,000
Value US$4,015,800
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
44.88
Quantity 34 -0.0%
Value US$1,526
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
44.17
Quantity 12,466 -6.9%
Value US$550,611
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Planned sale
Price
47.58
Quantity 61 -0.0%
Value US$2,902
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Planned sale
Price
47.14
Quantity 2,739 -1.4%
Value US$129,106
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Planned sale
Price
45.78
Quantity 9,700 -4.6%
Value US$444,027
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Planned sale
Price
48.32
Quantity 1,349 -0.7%
Value US$65,189
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Planned sale
Price
47.72
Quantity 11,151 -5.3%
Value US$532,137
1.8
Jonathan Young Officer Officer
Transaction date
Proposed sale
Price
48.28
Quantity 50,000
Value US$2,414,000
3.6
JANE HENDERSON Director Non-Executive Director
Transaction date
Proposed sale
Price
47.46
Quantity 3,000
Value US$142,372
3.6
Henderson Jane Non-Executive Director
Transaction date
Sale
Price
47.46
Quantity 3,000 -24.2%
Value US$142,371
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
49.44
Quantity 400 -0.1%
Value US$19,774
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
48.87
Quantity 18,805 -3.7%
Value US$918,906
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
48.07
Quantity 10,795 -2.1%
Value US$518,916
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
49.49
Quantity 6,962 -4.0%
Value US$344,577
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
49.07
Quantity 5,538 -3.1%
Value US$271,722
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
53.47
Quantity 1,342 -1.4%
Value US$71,762
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
52.87
Quantity 8,658 -8.5%
Value US$457,705
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
51.73
Quantity 15,314 -2.9%
Value US$792,224
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
50.57
Quantity 14,686 -2.7%
Value US$742,671
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
52.62
Quantity 41 -0.0%
Value US$2,157
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
52.00
Quantity 1,825 -1.1%
Value US$94,893
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
50.93
Quantity 10,634 -5.9%
Value US$541,611
4.1
Timothy Rolph Officer Officer
Transaction date
Proposed sale
Price
51.85
Quantity 56,250
Value US$2,916,563
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Planned sale
Price
52.88
Quantity 2,000 -6.3%
Value US$105,760
3.2
PATRICK D LAMY Officer Officer
Transaction date
Proposed sale
Price
53.36
Quantity 2,000
Value US$106,720
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Sale
Price
54.59
Quantity 875 -2.7%
Value US$47,766
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Sale
Price
54.84
Quantity 1,633 -1.8%
Value US$89,554
3.8
White William Richard Chief Financial Officer Officer
Transaction date
Sale
Price
54.84
Quantity 1,634 -2.8%
Value US$89,609
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Sale
Price
54.84
Quantity 1,453 -0.7%
Value US$79,683
2.9
Gangloff Scott A. Chief Technology Officer Officer
Transaction date
Sale
Price
54.84
Quantity 848 -3.5%
Value US$46,504
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Sale
Price
54.84
Quantity 1,129 -0.7%
Value US$61,914
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Sale
Price
54.84
Quantity 6,620 -1.2%
Value US$363,041
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
55.52
Quantity 895 -1.0%
Value US$49,690
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
54.80
Quantity 2,895 -3.0%
Value US$158,643
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
53.78
Quantity 6,210 -6.1%
Value US$333,974
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Planned sale
Price
55.09
Quantity 500 -1.5%
Value US$27,546
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Planned sale
Price
53.82
Quantity 1,500 -4.3%
Value US$80,726
1.8
Young Jonathan Chief Operating Officer Officer
Transaction date
Sale
Price
53.99
Quantity 2,493 -1.2%
Value US$134,605
3.8
White William Richard Chief Financial Officer Officer
Transaction date
Sale
Price
54.00
Quantity 2,804 -4.5%
Value US$151,402
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Sale
Price
54.00
Quantity 2,358 -1.4%
Value US$127,323
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Sale
Price
54.00
Quantity 919 -2.7%
Value US$49,625
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Sale
Price
53.99
Quantity 7,837 -1.4%
Value US$423,151
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
54.35
Quantity 15,158 -2.6%
Value US$823,883
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
53.76
Quantity 14,842 -2.5%
Value US$797,906
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Sale
Price
54.00
Quantity 2,803 -2.9%
Value US$151,351
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
55.04
Quantity 25,000 -12.8%
Value US$1,376,000
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
53.84
Quantity 3,150 -1.8%
Value US$169,596
4.1
Rolph Timothy Chief Scientific Officer Officer
Transaction date
Planned sale
Price
53.37
Quantity 9,350 -5.1%
Value US$499,038
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Planned sale
Price
51.04
Quantity 100 -0.3%
Value US$5,104
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Planned sale
Price
50.46
Quantity 3,300 -8.9%
Value US$166,515
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Planned sale
Price
49.40
Quantity 600 -1.6%
Value US$29,639
3.2
Lamy Patrick Senior VP, Commercial Strategy Officer
Transaction date
Planned sale
Price
50.00
Quantity 4,000 -10.7%
Value US$200,000
3.2
PATRICK D LAMY Officer Officer
Transaction date
Proposed sale
Price
48.35
Quantity 10,000
Value US$483,500
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
39.91
Quantity 4,384 -4.4%
Value US$174,948
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
39.46
Quantity 2,779 -2.7%
Value US$109,659
4.0
Yale Catriona Chief Development Officer Officer
Transaction date
Planned sale
Price
38.20
Quantity 2,837 -2.7%
Value US$108,371
4.0
CATRIONA YALE Officer Officer
Transaction date
Proposed sale
Price
37.88
Quantity 30,000
Value US$1,136,400
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
41.63
Quantity 22,800 -3.7%
Value US$949,255
3.3
Cheng Andrew President and CEO Executive Director
Transaction date
Planned sale
Price
41.00
Quantity 7,200 -1.2%
Value US$295,200
3.3
Andrew Cheng Officer Officer
Transaction date
Proposed sale
Price
39.85
Quantity 120,000
Value US$4,782,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-14 2025-10-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
83,338 +30.9%
113.80
US$3,062,554 		83,338 +30.9% 113.80 US$3,062,554
2025-10-09 2025-10-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
77,941 -29.8%
449.07
US$2,761,343 		77,941 -29.8% 449.07 US$2,761,343
2025-10-09 2025-10-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
21,281 +47.3%
321.29
US$2,152,867 		21,281 +47.3% 321.29 US$2,152,867
2025-10-07 2025-10-07 PrS Proposed sale
4.1
Timothy Rolph

Officer

Officer
56,369
46.04
US$2,595,229 		56,369 46.04 US$2,595,229
2025-10-03 2025-10-01 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
4,201 -2.1%
47.98
US$201,581 		4,201 -2.1% 47.98 US$201,581
2025-10-03 2025-10-01 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
8,299 -4.0%
47.64
US$395,398 		8,299 -4.0% 47.64 US$395,398
2025-09-12 2025-09-11 S Sale
1.8
Young Jonathan

Chief Operating Officer

Officer
586 -0.3%
43.02
US$25,210 		586 -0.3% 43.02 US$25,210
2025-09-12 2025-09-11 S Sale
3.8
White William Richard

Chief Financial Officer

Officer
659 -1.1%
43.02
US$28,350 		659 -1.1% 43.02 US$28,350
2025-09-12 2025-09-11 S Sale
3.3
Cheng Andrew

President and CEO

Executive Director
1,796 -0.4%
43.02
US$77,264 		1,796 -0.4% 43.02 US$77,264
2025-09-12 2025-09-11 S Sale
4.0
Yale Catriona

Chief Development Officer

Officer
659 -0.7%
43.02
US$28,350 		659 -0.7% 43.02 US$28,350
2025-09-12 2025-09-11 S Sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
553 -0.3%
43.02
US$23,790 		553 -0.3% 43.02 US$23,790
2025-09-12 2025-09-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
158 -0.0%
44.62
US$7,050 		158 -0.0% 44.62 US$7,050
2025-09-12 2025-09-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
7,317 -1.5%
44.00
US$321,911 		7,317 -1.5% 44.00 US$321,911
2025-09-12 2025-09-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
22,525 -4.5%
42.99
US$968,440 		22,525 -4.5% 42.99 US$968,440
2025-09-10 2025-09-10 PrS Proposed sale
3.3
Andrew Cheng

President, CEO and Director

Non-Executive Director
90,000
44.62
US$4,015,800 		90,000 44.62 US$4,015,800
2025-09-10 2025-09-08 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
34 -0.0%
44.88
US$1,526 		34 -0.0% 44.88 US$1,526
2025-09-10 2025-09-08 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
12,466 -6.9%
44.17
US$550,611 		12,466 -6.9% 44.17 US$550,611
2025-09-04 2025-09-02 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
61 -0.0%
47.58
US$2,902 		61 -0.0% 47.58 US$2,902
2025-09-04 2025-09-02 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
2,739 -1.4%
47.14
US$129,106 		2,739 -1.4% 47.14 US$129,106
2025-09-04 2025-09-02 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
9,700 -4.6%
45.78
US$444,027 		9,700 -4.6% 45.78 US$444,027
2025-08-13 2025-08-12 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
1,349 -0.7%
48.32
US$65,189 		1,349 -0.7% 48.32 US$65,189
2025-08-13 2025-08-12 PlS Planned sale
1.8
Young Jonathan

Chief Operating Officer

Officer
11,151 -5.3%
47.72
US$532,137 		11,151 -5.3% 47.72 US$532,137
2025-08-12 2025-08-12 PrS Proposed sale
1.8
Jonathan Young

Officer

Officer
50,000
48.28
US$2,414,000 		50,000 48.28 US$2,414,000
2025-08-12 2025-08-12 PrS Proposed sale
3.6
JANE HENDERSON

Director

Non-Executive Director
3,000
47.46
US$142,372 		3,000 47.46 US$142,372
2025-08-12 2025-08-12 S Sale
3.6
Henderson Jane
Non-Executive Director
3,000 -24.2%
47.46
US$142,371 		3,000 -24.2% 47.46 US$142,371
2025-08-13 2025-08-11 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
400 -0.1%
49.44
US$19,774 		400 -0.1% 49.44 US$19,774
2025-08-13 2025-08-11 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
18,805 -3.7%
48.87
US$918,906 		18,805 -3.7% 48.87 US$918,906
2025-08-13 2025-08-11 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
10,795 -2.1%
48.07
US$518,916 		10,795 -2.1% 48.07 US$518,916
2025-08-07 2025-08-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
6,962 -4.0%
49.49
US$344,577 		6,962 -4.0% 49.49 US$344,577
2025-08-07 2025-08-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
5,538 -3.1%
49.07
US$271,722 		5,538 -3.1% 49.07 US$271,722
2025-07-18 2025-07-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
1,342 -1.4%
53.47
US$71,762 		1,342 -1.4% 53.47 US$71,762
2025-07-18 2025-07-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
8,658 -8.5%
52.87
US$457,705 		8,658 -8.5% 52.87 US$457,705
2025-07-11 2025-07-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
15,314 -2.9%
51.73
US$792,224 		15,314 -2.9% 51.73 US$792,224
2025-07-11 2025-07-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
14,686 -2.7%
50.57
US$742,671 		14,686 -2.7% 50.57 US$742,671
2025-07-09 2025-07-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
41 -0.0%
52.62
US$2,157 		41 -0.0% 52.62 US$2,157
2025-07-09 2025-07-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
1,825 -1.1%
52.00
US$94,893 		1,825 -1.1% 52.00 US$94,893
2025-07-09 2025-07-07 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
10,634 -5.9%
50.93
US$541,611 		10,634 -5.9% 50.93 US$541,611
2025-07-07 2025-07-07 PrS Proposed sale
4.1
Timothy Rolph

Officer

Officer
56,250
51.85
US$2,916,563 		56,250 51.85 US$2,916,563
2025-07-03 2025-07-01 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
2,000 -6.3%
52.88
US$105,760 		2,000 -6.3% 52.88 US$105,760
2025-07-01 2025-07-01 PrS Proposed sale
3.2
PATRICK D LAMY

Officer

Officer
2,000
53.36
US$106,720 		2,000 53.36 US$106,720
2025-06-20 2025-06-20 S Sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
875 -2.7%
54.59
US$47,766 		875 -2.7% 54.59 US$47,766
2025-06-20 2025-06-18 S Sale
4.0
Yale Catriona

Chief Development Officer

Officer
1,633 -1.8%
54.84
US$89,554 		1,633 -1.8% 54.84 US$89,554
2025-06-20 2025-06-18 S Sale
3.8
White William Richard

Chief Financial Officer

Officer
1,634 -2.8%
54.84
US$89,609 		1,634 -2.8% 54.84 US$89,609
2025-06-20 2025-06-18 S Sale
1.8
Young Jonathan

Chief Operating Officer

Officer
1,453 -0.7%
54.84
US$79,683 		1,453 -0.7% 54.84 US$79,683
2025-06-20 2025-06-18 S Sale
2.9
Gangloff Scott A.

Chief Technology Officer

Officer
848 -3.5%
54.84
US$46,504 		848 -3.5% 54.84 US$46,504
2025-06-20 2025-06-18 S Sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
1,129 -0.7%
54.84
US$61,914 		1,129 -0.7% 54.84 US$61,914
2025-06-20 2025-06-18 S Sale
3.3
Cheng Andrew

President and CEO

Executive Director
6,620 -1.2%
54.84
US$363,041 		6,620 -1.2% 54.84 US$363,041
2025-06-20 2025-06-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
895 -1.0%
55.52
US$49,690 		895 -1.0% 55.52 US$49,690
2025-06-20 2025-06-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,895 -3.0%
54.80
US$158,643 		2,895 -3.0% 54.80 US$158,643
2025-06-20 2025-06-16 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
6,210 -6.1%
53.78
US$333,974 		6,210 -6.1% 53.78 US$333,974
2025-06-20 2025-06-16 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
500 -1.5%
55.09
US$27,546 		500 -1.5% 55.09 US$27,546
2025-06-20 2025-06-16 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
1,500 -4.3%
53.82
US$80,726 		1,500 -4.3% 53.82 US$80,726
2025-06-12 2025-06-10 S Sale
1.8
Young Jonathan

Chief Operating Officer

Officer
2,493 -1.2%
53.99
US$134,605 		2,493 -1.2% 53.99 US$134,605
2025-06-12 2025-06-10 S Sale
3.8
White William Richard

Chief Financial Officer

Officer
2,804 -4.5%
54.00
US$151,402 		2,804 -4.5% 54.00 US$151,402
2025-06-12 2025-06-10 S Sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
2,358 -1.4%
54.00
US$127,323 		2,358 -1.4% 54.00 US$127,323
2025-06-12 2025-06-10 S Sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
919 -2.7%
54.00
US$49,625 		919 -2.7% 54.00 US$49,625
2025-06-12 2025-06-10 S Sale
3.3
Cheng Andrew

President and CEO

Executive Director
7,837 -1.4%
53.99
US$423,151 		7,837 -1.4% 53.99 US$423,151
2025-06-12 2025-06-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
15,158 -2.6%
54.35
US$823,883 		15,158 -2.6% 54.35 US$823,883
2025-06-12 2025-06-10 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
14,842 -2.5%
53.76
US$797,906 		14,842 -2.5% 53.76 US$797,906
2025-06-12 2025-06-10 S Sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,803 -2.9%
54.00
US$151,351 		2,803 -2.9% 54.00 US$151,351
2025-06-09 2025-06-06 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
25,000 -12.8%
55.04
US$1,376,000 		25,000 -12.8% 55.04 US$1,376,000
2025-06-09 2025-06-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
3,150 -1.8%
53.84
US$169,596 		3,150 -1.8% 53.84 US$169,596
2025-06-09 2025-06-05 PlS Planned sale
4.1
Rolph Timothy

Chief Scientific Officer

Officer
9,350 -5.1%
53.37
US$499,038 		9,350 -5.1% 53.37 US$499,038
2025-06-04 2025-06-02 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
100 -0.3%
51.04
US$5,104 		100 -0.3% 51.04 US$5,104
2025-06-04 2025-06-02 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
3,300 -8.9%
50.46
US$166,515 		3,300 -8.9% 50.46 US$166,515
2025-06-04 2025-06-02 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
600 -1.6%
49.40
US$29,639 		600 -1.6% 49.40 US$29,639
2025-05-23 2025-05-22 PlS Planned sale
3.2
Lamy Patrick

Senior VP, Commercial Strategy

Officer
4,000 -10.7%
50.00
US$200,000 		4,000 -10.7% 50.00 US$200,000
2025-05-22 2025-05-22 PrS Proposed sale
3.2
PATRICK D LAMY

Officer

Officer
10,000
48.35
US$483,500 		10,000 48.35 US$483,500
2025-05-19 2025-05-15 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
4,384 -4.4%
39.91
US$174,948 		4,384 -4.4% 39.91 US$174,948
2025-05-19 2025-05-15 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,779 -2.7%
39.46
US$109,659 		2,779 -2.7% 39.46 US$109,659
2025-05-19 2025-05-15 PlS Planned sale
4.0
Yale Catriona

Chief Development Officer

Officer
2,837 -2.7%
38.20
US$108,371 		2,837 -2.7% 38.20 US$108,371
2025-05-15 2025-05-15 PrS Proposed sale
4.0
CATRIONA YALE

Officer

Officer
30,000
37.88
US$1,136,400 		30,000 37.88 US$1,136,400
2025-05-13 2025-05-12 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
22,800 -3.7%
41.63
US$949,255 		22,800 -3.7% 41.63 US$949,255
2025-05-13 2025-05-12 PlS Planned sale
3.3
Cheng Andrew

President and CEO

Executive Director
7,200 -1.2%
41.00
US$295,200 		7,200 -1.2% 41.00 US$295,200
2025-05-12 2025-05-12 PrS Proposed sale
3.3
Andrew Cheng

Officer

Officer
120,000
39.85
US$4,782,000 		120,000 39.85 US$4,782,000
Explore more

More insider trading research around Akero Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America